[go: up one dir, main page]

WO1998037181A3 - Gene de sous-unite catalytique de telomerase et proteine codee - Google Patents

Gene de sous-unite catalytique de telomerase et proteine codee Download PDF

Info

Publication number
WO1998037181A3
WO1998037181A3 PCT/US1998/003404 US9803404W WO9837181A3 WO 1998037181 A3 WO1998037181 A3 WO 1998037181A3 US 9803404 W US9803404 W US 9803404W WO 9837181 A3 WO9837181 A3 WO 9837181A3
Authority
WO
WIPO (PCT)
Prior art keywords
catalytic subunit
malignancy
telomerase
encoded protein
subunit gene
Prior art date
Application number
PCT/US1998/003404
Other languages
English (en)
Other versions
WO1998037181A2 (fr
Inventor
Christopher M Counter
Matthew Meyerson
Robert A Weinberg
Original Assignee
Whitehead Biomedical Inst
Christopher M Counter
Matthew Meyerson
Robert A Weinberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst, Christopher M Counter, Matthew Meyerson, Robert A Weinberg filed Critical Whitehead Biomedical Inst
Publication of WO1998037181A2 publication Critical patent/WO1998037181A2/fr
Publication of WO1998037181A3 publication Critical patent/WO1998037181A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Cette invention concerne de l'ADN isolé codant la sous-unité catalytique d'une holoenzyme de télomérase eucaryotique telle que la sous-unité catalytique d'une holoenzyme de télomérase humaine ou de levure; le transcript d'ARN qui est exprimé dans des tumeurs humaines primitives, des lignées cellulaires cancéreuses et des tissus télomérase-positifs; et la protéine de sous-unité catalytique codée. L'invention concerne également des procédés qui permettent d'évaluer le caractère malin des cellules ou la probabilité accrue que les cellules deviennent malignes et des méthodes de diagnostic ou facilitant le diagnostic du développement du caractère malin des cellules chez un individu.
PCT/US1998/003404 1997-02-20 1998-02-20 Gene de sous-unite catalytique de telomerase et proteine codee WO1998037181A2 (fr)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US3875097P 1997-02-20 1997-02-20
US60/038,750 1997-02-20
US4715197P 1997-05-20 1997-05-20
US60/047,151 1997-05-20
US5454997P 1997-08-01 1997-08-01
US60/054,549 1997-08-01
US5576297P 1997-08-14 1997-08-14
US60/055,762 1997-08-14
US6432297P 1997-10-30 1997-10-30
US60/064,322 1997-10-30

Publications (2)

Publication Number Publication Date
WO1998037181A2 WO1998037181A2 (fr) 1998-08-27
WO1998037181A3 true WO1998037181A3 (fr) 1999-02-18

Family

ID=27534674

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/003404 WO1998037181A2 (fr) 1997-02-20 1998-02-20 Gene de sous-unite catalytique de telomerase et proteine codee

Country Status (1)

Country Link
WO (1) WO1998037181A2 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517971B1 (en) 1996-10-01 2009-04-14 Geron Corporation Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
US7560437B2 (en) 1996-10-01 2009-07-14 Geron Corporation Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59609347D1 (de) 1995-11-16 2002-07-18 Michael W Dahm Verfahren zur quantifizierung von tumorzellen in einer körperflüssigkeit und dazu geeignete testkits
US6093809A (en) 1996-10-01 2000-07-25 University Technology Corporation Telomerase
US6261836B1 (en) 1996-10-01 2001-07-17 Geron Corporation Telomerase
US6777203B1 (en) 1997-11-19 2004-08-17 Geron Corporation Telomerase promoter driving expression of therapeutic gene sequences
US6610839B1 (en) 1997-08-14 2003-08-26 Geron Corporation Promoter for telomerase reverse transcriptase
US7622549B2 (en) 1997-04-18 2009-11-24 Geron Corporation Human telomerase reverse transcriptase polypeptides
US7413864B2 (en) 1997-04-18 2008-08-19 Geron Corporation Treating cancer using a telomerase vaccine
WO1998059040A2 (fr) * 1997-06-20 1998-12-30 Bayer Aktiengesellschaft Sous-unite de telomerase catalytique humaine et son utilisation therapeutique et diagnostique
CA2294782A1 (fr) 1997-07-01 1999-01-14 Cambia Biosystems Llc Genes et proteines telomerase de vertebres et leurs utilisations
EP1571215A3 (fr) * 1997-07-01 2007-10-31 Cambia Biosystems LLC Gènes et protéines de télomérases de vertèbres et leurs utilisations
US7378244B2 (en) 1997-10-01 2008-05-27 Geron Corporation Telomerase promoters sequences for screening telomerase modulators
WO1999027113A1 (fr) * 1997-11-26 1999-06-03 Geron Corporation Transcriptase inverse de telomerase de souris
WO1999035261A1 (fr) 1998-01-08 1999-07-15 Chugai Seiyaku Kabushiki Kaisha Nouveau gene presentant un motif de transcriptase inverse
DE19804372A1 (de) * 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Verfahren zur quantitativen Bestimmung von Tumorzellen in einer Körperflüssigkeit und dazu geeignete Testkits
CA2291798A1 (fr) * 1998-03-26 1999-10-07 Kyowa Hakko Kogyo Co., Ltd. Anticorps monoclonal contre une sous-unite catalytique de telomerase humaine
WO1999050392A1 (fr) 1998-03-31 1999-10-07 Geron Corporation Techniques et compositions permettant de faire apparaitre une reponse immunitaire a un antigene de telomerase
US7402307B2 (en) 1998-03-31 2008-07-22 Geron Corporation Method for identifying and killing cancer cells
US6337200B1 (en) 1998-03-31 2002-01-08 Geron Corporation Human telomerase catalytic subunit variants
AU1331100A (en) 1998-10-29 2000-05-22 Dana-Farber Cancer Institute Cancer immunotheraphy and diagnosis using universal tumor associated antigens, including htert
US6825397B1 (en) 1998-11-09 2004-11-30 Pioneer Hi-Bred International, Inc. LEC1 trancriptional activator nucleic acids and methods of use thereof
WO2000031238A2 (fr) * 1998-11-25 2000-06-02 Genetica, Inc. Methodes et reactifs d'augmentation de la capacite proliferative et de prevention de la senescence replicative
KR100801764B1 (ko) * 1999-09-17 2008-02-05 레뉴런 리미티드 세포의 조건부 불멸화
US6399384B1 (en) 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells
US6492171B2 (en) 2000-05-16 2002-12-10 Isis Pharmaceuticals, Inc. Antisense modulation of TERT expression
US6331399B1 (en) 2000-05-16 2001-12-18 Isis Pharmaceuticals, Inc. Antisense inhibition of tert expression
AU2001282290A1 (en) * 2000-08-17 2002-03-04 University Of Wales College Of Medicine Htert-immortalised cell lines, their preparation and use
US7078491B1 (en) * 2000-09-21 2006-07-18 Amgen Inc. Selective binding agents of telomerase
GB0125773D0 (en) * 2001-10-26 2001-12-19 Reneuron Ltd Constructs
US20050089895A1 (en) * 2003-08-13 2005-04-28 Cheung Siu T. Compositions and methods for prognosis and therapy of liver cancer
RU2473691C2 (ru) 2006-10-12 2013-01-27 Институто Ди Ричерке Ди Биолоджиа Молеколаре П.Анджелетти Спа Слитый белок теломеразной обратной транскриптазы, кодирующие его нуклеотиды и их применение
US10689652B2 (en) 2013-10-02 2020-06-23 The Regents Of The University Of California Methods for immortalization of epithelial cells
US10870851B2 (en) 2015-10-06 2020-12-22 The Regents Of The University Of California Non-coding RNAs linked to immortality and associated methods and compositions

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023572A1 (fr) * 1992-05-13 1993-11-25 University Of Texas Southwestern Medical Center At Dallas Therapie et diagnostic des etats pathologiques lies a la longueur du telomere et/ou a l'activite de la telomerase
WO1996001835A1 (fr) * 1994-07-07 1996-01-25 Geron Corporation Telomerase mammifere
WO1996012811A2 (fr) * 1994-10-20 1996-05-02 Arch Development Corporation Constituants de levure-telomerase et leurs procedes d'utilisation
WO1998001542A1 (fr) * 1996-07-08 1998-01-15 The Regents Of The University Of California Telomerase humaine
GB2317891A (en) * 1996-10-01 1998-04-08 Geron Corp hTRT, the reverse transcriptase subunit of human telomerase
WO1998021343A1 (fr) * 1996-11-15 1998-05-22 Amgen Inc. Genes codant des proteines de telomerase

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023572A1 (fr) * 1992-05-13 1993-11-25 University Of Texas Southwestern Medical Center At Dallas Therapie et diagnostic des etats pathologiques lies a la longueur du telomere et/ou a l'activite de la telomerase
WO1996001835A1 (fr) * 1994-07-07 1996-01-25 Geron Corporation Telomerase mammifere
WO1996012811A2 (fr) * 1994-10-20 1996-05-02 Arch Development Corporation Constituants de levure-telomerase et leurs procedes d'utilisation
WO1998001542A1 (fr) * 1996-07-08 1998-01-15 The Regents Of The University Of California Telomerase humaine
GB2317891A (en) * 1996-10-01 1998-04-08 Geron Corp hTRT, the reverse transcriptase subunit of human telomerase
WO1998021343A1 (fr) * 1996-11-15 1998-05-22 Amgen Inc. Genes codant des proteines de telomerase

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
COUNTER C M ET AL: "The catalytic subunit of yeast telomerase", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 94, no. 17, 1997, WASHINGTON US, pages 9202 - 9207, XP002071610 *
GREIDER C W: "TELOMERE LENGTH REGULATION", ANNUAL REVIEW OF BIOCHEMISTRY, vol. 65, 1996, PALO ALTO US, pages 337 - 365, XP002056801 *
HARRINGTON L ET AL: "HUMAN TELOMERASE CONTAINS EVOLUTIONARILY CONSERVED CATALYTIC AND STRUCTURAL SUBUNITS", GENES AND DEVELOPMENT, vol. 11, no. 23, 1 December 1997 (1997-12-01), COLD SPRING HARBOUR US, pages 3109 - 3115, XP002061269 *
LENDVAY T S ET AL: "Senescence mutants of Saccharomyces cerevisiae with a defect in telomere replication identify three additional EST genes", GENETICS, vol. 144, no. 4, 1996, BETHESDA US, pages 1399 - 1412, XP002071608 *
LINGNER J ET AL: "Reverse transcriptase motifs in the catalytic subunit of telomerase", SCIENCE., vol. 276, no. 5312, 25 April 1997 (1997-04-25), LANCASTER, PA US, pages 561 - 567, XP002071609 *
MEYERSON M ET AL: "HEST2, THE PUTATIVE HUMAN TELOMERASE CATALYTIC SUBUNIT GENE, IS UP-REGULATED IN TUMOR CELLS AND DURING IMMORTALIZATION", CELL, vol. 90, no. 4, 22 August 1997 (1997-08-22), NA US, pages 785 - 795, XP002056804 *
NAKAMURA T M ET AL: "TELOMERASE CATALYTIC SUBUNIT HOMOLOGS FROM FISSION YEAST AND HUMAN", SCIENCE., vol. 277, 15 August 1997 (1997-08-15), LANCASTER, PA US, pages 955 - 959, XP002056803 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7517971B1 (en) 1996-10-01 2009-04-14 Geron Corporation Muteins of human telomerase reverse transcriptase lacking telomerase catalytic activity
US7560437B2 (en) 1996-10-01 2009-07-14 Geron Corporation Nucleic acid compositions for eliciting an immune response against telomerase reverse transcriptase
US7585622B1 (en) 1996-10-01 2009-09-08 Geron Corporation Increasing the proliferative capacity of cells using telomerase reverse transcriptase

Also Published As

Publication number Publication date
WO1998037181A2 (fr) 1998-08-27

Similar Documents

Publication Publication Date Title
WO1998037181A3 (fr) Gene de sous-unite catalytique de telomerase et proteine codee
WO1999064576A3 (fr) Nouveaux genes humains et produits d'expression genique
WO2002010382A3 (fr) Marqueurs trp8, trp9 et trp10 associes au cancer
AU3246300A (en) Polypeptides having galactose oxidase activity and nucleic acids encoding same
ES2255281T3 (es) Sobreexpresion de genes de fitasa en sistmas de levadura.
WO1999040189A3 (fr) ADNc CODANT DES PROTEINES SECRETEES
WO2001034802A3 (fr) Compositions et methodes de traitement et de diagnostic du cancer de la prostate
WO1999031236A3 (fr) ADNc PROLONGES POUR PROTEINES SECRETEES
WO2001025272A3 (fr) Compositions et methodes de therapie et de diagnostic du cancer de la prostate
WO2002029086A3 (fr) Sequences d'acide nucleique differentiellement exprimees dans un tissu cancereux
WO2001072295A3 (fr) Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon
WO2000024365A8 (fr) Traitement de la peau au moyen d'adenosine ou d'un analogue d'adenosine
WO2002004514A8 (fr) Compositions et procedes pour le traitement et le diagnostic du cancer du poumon
WO2000050588A3 (fr) Genes associes a des maladies du colon
WO2000042208A8 (fr) Vecteurs d'adenovirus, lignees cellulaires d'encapsidation, compositions et procedes de preparation et d'utilisation correspondants
WO2000052136A3 (fr) Enzymes de glycosylation humaines
WO2003066663A3 (fr) Peptides utilises pour reconnaitre et cibler des tumeurs de cellules gliales
WO2001041815A3 (fr) Genes de metastase et utilisations de tels genes
EP1199364A3 (fr) Utilisation d'enzymes recombinantes pour la préparation de GDP-L-fucose et de glycanes fucosylés
WO2002072785A3 (fr) Acide nucleique et proteine correspondante denommes 125p5c8 utiles dans le traitement et la detection de cancers
WO2001098469A3 (fr) Polypeptides presentant une activite de la peroxydase et acides nucleiques codant pour ces polypeptides
WO2000028043A3 (fr) Polypeptides presentant une activite lactonohydrolase et acides nucleiques codant ces polypeptides
WO2001038577A3 (fr) Transcriptomes humains
WO2002083919A3 (fr) Acide nucleique et proteine correspondante intitulee 184p1e2, utilises dans le traitement et la detection de cancers
CA2315239A1 (fr) Sequence nucleotidique et proteinique de la mammastatine et procedes d'utilisation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): CA US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase